Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Debt Ratio: 2012-2025

Historic Debt Ratio for Adma Biologics (ADMA) over the last 9 years, with Sep 2025 value amounting to 0.13.

  • Adma Biologics' Debt Ratio fell 50.90% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 50.90%. This contributed to the annual value of 0.15 for FY2024, which is 62.69% down from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Debt Ratio is 0.13, which was down 3.11% from 0.13 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Debt Ratio registered a high of 0.47 during Q2 2022, and its lowest value of 0.13 during Q3 2025.
  • Over the past 3 years, Adma Biologics' median Debt Ratio value was 0.35 (recorded in 2024), while the average stood at 0.29.
  • Its Debt Ratio has fluctuated over the past 5 years, first climbed by 19.36% in 2022, then slumped by 62.69% in 2024.
  • Over the past 5 years, Adma Biologics' Debt Ratio (Quarterly) stood at 0.34 in 2021, then grew by 19.36% to 0.41 in 2022, then fell by 3.21% to 0.40 in 2023, then crashed by 62.69% to 0.15 in 2024, then plummeted by 50.90% to 0.13 in 2025.
  • Its last three reported values are 0.13 in Q3 2025, 0.13 for Q2 2025, and 0.14 during Q1 2025.